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Abstract
The human opportunistic pathogen Candida albicans undergoes a reversible morphological transition between the yeast
and hyphal states in response to a variety of signals. One such environmental trigger is growth within a semisolid matrix
such as agar medium. This growth condition is of interest because it may mimic the growth of C. albicans in contact with
host tissue during infection. During growth within a semisolid matrix, hyphal growth is positively regulated by the
transcriptional regulator Czf1p and negatively by a second key transcriptional regulator, Efg1p. Genetic studies indicate that
Czf1p, a member of the zinc-cluster family of transcriptional regulators, exerts its function by opposing the inhibitory
influence of Efg1p on matrix-induced filamentous growth. We examined the importance of the two known activities of
Czf1p, DNA-binding and interaction with Efg1p. We found that the two activities were separable by mutation allowing us to
demonstrate that the DNA-binding activity of Czf1p was essential for its role as a positive regulator of morphogenesis.
Surprisingly, however, interactions with Efg1p appeared to be largely dispensable. Our studies provide the first evidence of
a key role for the DNA-binding activity of Czf1p in the morphological yeast-to-hyphal transition triggered by matrix-
embedded growth.
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Introduction
Candida albicans is a diploid fungus that has adapted primarily for
survival as a commensal of mammalian hosts. It is a common
member of the human microbiota of the gastrointestinal tract,
mucus membranes and the skin. In instances when the host
immune system is weakened (for example, during immunosup-
pression therapy or in neonates) or the competing microflora is
eliminated (for example, during antibiotic treatment) the organism
can cause a range of diseases [1]. Oral thrush is an example of
a superficial mucosal infection caused by C. albicans. If the
organism gains access to the bloodstream, a condition known as
candidaemia, it may cause a life-threatening systemic disease.
Such Candida infections are the fourth-leading cause of nosocomial
disease in the United States [2].
The organism’s adaptability for survival in a range of niches
within the host is in great part due to its highly plastic behavior.
For example, growth of C. albicans can be in the yeast form or
either of two filamentous states: pseudohyphae or true hyphae [3].
The transition between the different morphological forms is
reversible. Filamentous growth is thought to help C. albicans invade
and penetrate tissue, escaping the original site of infection and
reaching distal sites, while growth in the yeast form may be better
suited for dissemination in the bloodstream. As a result, poly-
morphic growth is considered to be an important virulence trait of
C. albicans [4]. This is supported by studies showing that mutants
locked in one morphological state or another are attenuated for
virulence [5,6]. A mutant of hgc1, a hypha specific cyclin, that is
defective in filamentous growth but expresses several hypha-
associated genes, is also attenuated for virulence in the mouse
model of systemic infection [7].
A variety of signals trigger the yeast-to-hyphal transition. In
a laboratory setting, several of these are growth at 37uC in the
presence of serum, alkaline pH or a nitrogen limiting environment
[3]. A large network of connections is involved in the control of
morphogenesis and is responsive to a range of hyphal-inducing
signals. Two highly conserved pathways, the cAMP dependent
protein kinase A (PKA) and the mitogen activated protein kinase
(MAPK) pathway, are at the heart of the network and have
a positive effect on the morphological switch [5]. Mutations in
components that lie within the two pathways (for recent review,
see [8]) and in particular, the downstream transcriptional
regulators Efg1p of the cAMP-PKA pathway and Cph1p of the
MAPK pathway, lead to defects in filamentous growth [5,9,10,11].
A strain lacking both EFG1 and CPH1 exhibits a dramatic defect
in filament formation during most hyphal-inducing conditions,
and is avirulent in a model of systemic infection in the mouse [5].
However, interestingly, in an alternative model of C. albicans
infection, an efg1D cph1D mutant is able to filament and invade
tissue [12].
Growth within semi-solid agar matrix is an environmental
condition that triggers morphogenesis, and may mimic the
encounter and growth of C. albicans in contact with tissue [13].
Here, a control mechanism distinct from that seen during other
hypha-inducing conditions at 37uC is active. Efg1p, required for
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effect on this process during matrix-embedded growth at 25uC
[14]. A second pathway mediated by the transcriptional regulator
Czf1p relieves the inhibitory effect of Efg1p and promotes
morphogenesis [13,14]. Cph1p promotes filamentation, but has
a more minor role during this process [14]. Ectopic expression or
deletion of CZF1 do not enhance or reduce filamentation during
embedded growth in the absence of Efg1p, making the efg1D
mutant phenotype epistatic to that of a czf1D mutant. The epistatic
interactions during matrix-embedded growth at 25uC point to
a functional relationship between Czf1p and Efg1p where Czf1p
relieves Efg1p-mediated inhibition of filamentation.
EFG1 encodes a DNA-binding protein of the APSES family of
fungal transcriptional regulators with a multitude of functions in C.
albicans [11,15,16,17]. In the absence of EFG1, a number of genes
are either up or downregulated [15,16,18,19]. The precise timing
and magnitude of EFG1 expression is essential for its function in
morphogenesis [11,20]. Efg1p, characterized by a conserved helix-
loop-helix (bHLH) domain involved in DNA-binding, binds to
EGR elements found in promoter regions of target genes during
yeast growth [21]. Induction of hyphal growth is associated with
a shift of Efg1p binding away from these elements to several other
sequences that have similarities with other regulatory sequences
[21]. Efg1p is thought to direct downstream effects both directly
and indirectly, through intermediate transcriptional regulators.
CZF1 encodes a DNA-binding protein of the Cys6Zn2 class of
transcriptional regulators [13,22,23]. CZF1 expression is regulated
by a variety of environmental conditions such as carbon source,
growth phase, temperature and the physical environment, and the
CZF1 promoter region appears to be under complex regulatory
control [17,21,24]. Interestingly, CZF1 expression is Efg1p de-
pendent under all conditions tested [24]. It is also subject to
negative autoregulation [24]. A czf1D mutant has a defect in
filamentation during embedded growth but not during other liquid
based hypha-inducing conditions pointing to the specific role of
Czf1p in the control of matrix-induced filamentation [13].
How Czf1p and Efg1p work together to control morphogenesis
is not understood. Czf1p binds to DNA [23] and physically
interacts with Efg1p [14]. The biological function of the protein’s
DNA-binding activity and the significance of the Czf1p-Efg1p
interaction in the control of matrix-induced filamentation have not
been previously studied. Here, we show that the DNA-binding
activity of Czf1p and the ability to interact with Efg1p could be
separated by mutation. We also show that DNA-binding of Czf1p
is essential for its regulatory function and role as a positive
regulator of filamentation, whereas interaction with Efg1p is
dispensable for this function.
Results
czf1 point mutants defective in the yeast-to-hyphal
morphological transition during matrix-embedded
growth
Czf1p belongs to a class of transcriptional regulators that possess
a well-conserved Cys6Zn2 motif, with six cysteines binding to two
zinc atoms and coordinating the fold of the domain [22]. While
the majority of zinc-finger proteins bind to DNA, functionally they
are very diverse. For example, the Cys6Zn2 motif has been
implicated in physiological roles such as zinc sensing, chromatin
remodeling and protein interactions [25,26]. Whether the
Cys6Zn2 motif of Czf1p is important for its role as a positive
regulator of matrix-induced filamentation and is involved in DNA-
binding had not been explored. We examined the possible
contribution of residues within this domain to the function of
Czf1p as a positive regulator of morphogenesis during embedded
growth.
Using the structure of Saccharomyces cerevisiae Gal4p, a DNA-
binding protein and activator of GAL genes for comparison, we
identified conserved residues in the putative zinc-finger domain of
Czf1p that were predicted to contact DNA, Arg321 and Lys322
(FIG 1). In order to test their contribution to DNA-binding and
Czf1p activity, we substituted each residue with an alanine. We
also constructed an alanine substitution mutation of Thr328
because an analogous residue in Leu3p, His50, contributes to the
function of the protein as a repressor [27].
Constructs carrying CZF1-myc, czf1T328A-myc, czf1R321A-myc or
czf1K322A-myc were introduced into a czf1D cph1D null strain in
order to test their effects on filamentation during matrix-
embedded growth at 25uC. The double null mutant is very
defective in filamentation under embedded conditions facilitating
analysis of mutant phenotypes.
Strains carrying these CZF1 alleles were grown embedded in
YPS agar at 25uC and representative colony images are shown in
Figure 2A. Filamentous colonies were counted at the times
indicated, as described in Materials and Methods (FIG 2B). In
strains carrying either wild-type CZF1-myc or CZF1T328A-myc,
filamentation initiated at around the 72-hour time-point and about
fifty percent of colonies were filamentous at 96 hours. Strains
carrying czf1R321A-myc or czf1K322A-myc were highly defective in
filamentation and resembled the czf1D cph1D double null mutant
during the first 96 hours of growth under embedded conditions.
After this time point, the czf1R321A-myc strain remained primarily
non-filamentous like the czf1D cph1D double null strain, whereas
the czf1K322A-myc strain showed some increase in filamentation. At
96 hours, differences in the percent of filamentous colonies
between CZF1-myc and either czf1R321A-myc or czf1K322A-myc were
statistically significant (Table 1).
When untagged alleles were analyzed in a Ura
+ strain
background, similar relative effects were observed (Table 1),
demonstrating a statistically significant defect in formation of
filamentous colonies for czf1R321A and czf1K322A strains in
comparison to the CZF1
+ strain. Furthermore, expression of
Region A Region B
Consensus
B
A
Gln ZnF
54 315 342 385
Figure 1
Gal4p 11- -38
Czf1p 315- -342
Figure 1. Conserved residues of Czf1p. (Panel A) Diagram of Czf1p.
Numbers indicate amino acid residues. Gln, glutamine rich region. ZnF,
zinc finger motif. (Panel B) Alignment of the zinc-finger motif amino
acid sequence of Czf1p (residues 315–342) and S. cerevisiae Gal4p
(residues 11–38). Marked regions A and B, and consensus sequence are
from Corton et al. (1998) and are based on amino acids that are
conserved in more than 33% of sequences from 79 Cys6Zn2 fungal
proteins. Lys17 and Lys18 in Gal4p make direct contacts with the target
DNA sequence. Underlined residues in the Czf1p amino acid sequence
were targeted in this study.
doi:10.1371/journal.pone.0039624.g001
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PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e39624Figure 2. Filamentation of czf1 mutants during growth under matrix-embedded conditions. Cells of czf1D cph1D mutant strains carrying
Myc-tagged wild type CZF1 under control of the maltase promoter, Myc-tagged mutant CZF1 under control of the maltase promoter or vector alone
were embedded in YPS + uridine, 1% agar and grown at 25uC. Two independent isolates of each strain were tested in duplicate. (Panel A)
Representative colonies were photographed at 10x at the times indicated. (Panel B) The percentage of filamentous colonies for a given strain at
various times was measured as described in Materials and Methods. Data show the mean of the 4 determinations and the standard deviation. Black
bar, czf1D (IPC11); white bar, CZF1
+-myc (IPC22); horizontal lines, CZF1T328A-myc (IPC51); grey bar, czf1K322A-myc (IPC31); vertical lines, czf1R321A-myc
(IPC42). (Panel C) Cells were grown in liquid YPS medium at 30uC and 30 mg of total protein was fractionated by SDS PAGE. Immunoblot analysis was
performed using an anti-Myc antibody to detect tagged Czf1 proteins. Actin was detected with anti-actin as a loading control.
doi:10.1371/journal.pone.0039624.g002
Table 1. Defects in filamentation under embedded conditions at 96 hours.
Strain background CZF1 allele
a
Percent filamentous
colonies
b p value (vs CZF1-myc)
c p value (vs CZF1
+)
c
czf1D cph1D Ura
2 czf1D 963 ,0.001
czf1D cph1D Ura
2 CZF1-myc 58614
czf1D cph1D Ura
2 CZF1T328A-myc 5067 ,0.35
czf1D cph1D Ura
2 czf1K322A-myc 763 ,0.001
czf1D cph1D Ura
2 czf1R321A-myc 762 ,0.001
czf1D cph1D Ura
+ czf1D 461 ,0.000001
czf1D cph1D Ura
+ CZF1
+ 9863
czf1D cph1D Ura
+ CZF1T328A 9863 ,0.78
czf1D cph1D Ura
+ czf1K322A 3265 ,0.0001
czf1D cph1D Ura
+ czf1R321A 563 ,0.00001
aAllele carried on plasmid, under control of Maltase promoter, integrated at ADE2 locus.
bMean6standard deviation; three determinations for untagged CZF1 strains; four determinations for tagged CZF1 strains.
CBy two-tailed t test.
doi:10.1371/journal.pone.0039624.t001
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were present on the chromosome did not cause a defect in
filamentation suggesting that the czf1 mutants were loss of function
mutants (data not shown).
To show that the defective mutant proteins were produced
normally, extracts of cells carrying myc-tagged alleles were
analyzed by immunoblotting analysis with anti-myc antibody.
Results showed that wild-type and mutant Czf1 proteins were
present at similar levels (FIG 2C).
These results demonstrate that, as in Gal4p and other members
of this family, two residues in region A of Czf1p, the highly
conserved Arg321 and Lys322, contribute to the function of the
protein in invasive filamentation. In contrast, Thr328 in region B
does not appear to be important.
czf1 mutants are defective in DNA-binding to a target
DNA sequence
Czf1p binds to specific fragments of the CZF1 promoter region,
but not to promoter sequences of the ACT1 and SOD3 genes [23].
To test the DNA-binding activities of the Czf1pR321A and
Czf1pK322A mutants, GST fusions of wild-type and mutant Czf1p
were expressed in Escherichia coli and purified by standard methods
(FIG 3A).
To test the abilities of these proteins to bind DNA we used
a known Czf1p target DNA sequence (fragment E) located at
positions 23381 to 22816 relative to the start of the CZF1 ORF.
This region of the promoter is immediately upstream of the
transcriptional start site [23].
Figure 3B shows that DNA-binding by wild-type GST-Czf1p
was detectable at a concentration as low as 25 nM and became
more robust as protein concentration increased. At lower protein
amounts, a single protein-DNA complex was observed, while at
higher protein concentrations multiple complexes were detected.
In previous studies, we showed that the two complexes formed by
binding of Czf1p to fragment E were not observed when another
fragment of the CZF1 promoter was used as the probe,
demonstrating binding specificity [23].
Binding of GST-Czf1K322A to DNA was detectable at protein
concentrations of 25–50 nM but the amount was low and the
lower molecular weight species was most predominant. At 0.8 mM
the pattern of protein-DNA complexes was different from that of
wild-type GST-Czf1p. Thus, to achieve the level of binding seen
with a given concentration of WT GST-Czf1p, higher concentra-
tions of GST-Czf1K322A were required.
Binding of GST-Czf1R321A had a more dramatic defect and no
DNA-binding activity was observed at any protein concentration
tested. Therefore, one highly conserved residue within the
Cys6Zn2 motif was essential for Czf1p target DNA-binding and
important for Czf1p function as a regulator of filamentation.
Czf1p DNA-binding and interaction with Efg1p are
independent of one another
Epistasis studies point to a Czf1p and Efg1p genetic interaction
during matrix-embedded growth [14]. Yeast-two-hybrid analysis
further supports the notion of an in vivo physical interaction
between the two transcriptional regulators. The significance of this
physical interaction is unclear.
To test the effects of the czf1R321A and czf1K322A mutations on
Czf1p-Efg1p two-hybrid interaction, we performed a yeast two-
hybrid assay. S. cerevisiae strain EGY40 carrying a lacZ reporter
gene with lexA operator sites was transformed with LexA DNA-
binding domain plasmids (either CZF1–lexA or the control fusion
lexA-FOS). Gal4 activation domain fusions (either GAL4AD-Efg1
or the control fusion GAL4AD-Slk19) were introduced into these
strains. As expected, strains carrying the control fusion proteins,
Gal4AD-Slk19 and LexA-Fos produced low levels of b-galactosi-
dase activity (FIG 4A), demonstrating that these fusions did not
interact with Czf1p and Efg1p, respectively, nor did they interact
with one another. b-galactosidase activity in transformants
A
B
CZF1
0 0.025 0.05 0.1 0.2 0.4 0.8µM
0 0.025 0.05 0.1 0.2 0.4 0.8µM
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GST-Czf1R321A
GST-Czf1K322A
GST-Czf1
70 kDa
R321A Czf1
A
K322A
GST GST GST
Figure 3
80 kDa
Figure 3. EMSA of wild type and mutant Czf1p binding to the
CZF1 promoter region. (Panel A) SDS PAGE analysis of 500 ng of
purified wild type and mutant GST-Czf1 fusion proteins stained with
Coomassie Blue. (Panel B) Diagram of the CZF1 promoter region (not
drawn to scale). The DNA fragment used in this study (fragment E,
565 bp) is represented as a black rectangle and is located 23381 to
22816 from the ATG start of the CZF1 ORF. The transcriptional start site
is represented as an arrow and is located at 22065 from the ATG [23].
(Panels C–E) Increasing amounts of GST-Czf1p were incubated with
32P
end-labelled fragment E. The samples were analyzed by electrophoretic
mobility shift assay and phosphorimaging. Brackets indicate shifted
fragments. All EMSA experiments were repeated at least 3 times and
a representative experiment is shown.
doi:10.1371/journal.pone.0039624.g003
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that of transformants carrying control fusions (Gal4AD-Slk19 and
LexA-Fos) (FIG 4A), consistent with previous results [14].
Importantly, the Czf1R321A and Czf1K322A fusion proteins
interacted with Gal4AD-Efg1 similarly to wild-type Czf1p
(FIG 4A). In addition, wild-type and mutant Czf1p fusions showed
similar protein levels (FIG 4B).
Therefore, by individually introducing single amino-acid
changes into the zinc-finger motif of Czf1p, we generated czf1
mutants that were defective in DNA-binding, but not in
interaction with Efg1p. As a result, we separated the two known
activities of Czf1p and showed that a DNA binding defect confers
a czf1 mutant phenotype. These results provide the first evidence
of a key role for the DNA-binding activity of Czf1p in regulating
the morphological yeast-to-hyphal transition triggered by matrix-
embedded growth.
Interaction between Czf1p and Efg1p has a minor role
during matrix-embedded growth
To test the importance of the physical interaction between
Efg1p and Czf1p we analyzed a previously characterized mutant
form of Efg1p, Efg1-D3, that is compromised in the ability to bind
Czf1p in the two-hybrid assay [28]. Efg1-D3 is deleted for amino
acids 131–202, adjacent to the APSES domain of the protein [28].
Wild-type EFG1 and EFG1-D3 were introduced into an efg1D
strain background and the ability of the strains to produce
filamentous colonies during embedded growth at 23uC was
measured.
As shown in Figure 5A and 5B, at a time when the wild-type
strain maintained growth in the yeast state, an efg1D null strain was
hyperfilamentous, consistent with previous results [14]. Introduc-
ing one copy of EFG1
+ partially complemented the efg1D mutant
phenotype, as observed previously. A strain carrying EFG1-D3
behaved very similarly to the wild-type complemented strain. By
detecting the HA tag at the N-terminus of the protein, we showed
that the wild-type and mutant Efg1p were produced in similar
amounts, consistent with previous reports [28]. Because the efg1D
cph1D double null mutant behaved similarly to wild-type C. albicans
[14], EFG1-D3 was not tested in this strain background.
In summary, during matrix-embedded growth, the EFG1-D3
allele had wild type filamentation. Previous results showed that
EFG1-D3 has no defect in hyphal induction in various other media
at 37uC, but has a slight defect in the maintenance of the white
state in a WO-1 strain of C. ablicans [28]. Thus, the interaction
between Czf1p and Efg1p mediated by the D3 region of Efg1p is
dispensable for the control of morphogenesis during embedded
growth, as well as under other conditions.
Discussion
The contributions of the two known activities of Czf1p to its
function as a positive regulator of filamentation had not been
previously explored. Here, for the first time, we provide evidence
for the biological significance of the DNA-binding activity of
Czf1p. A czf1 mutant, Czf1R321A, was defective during in vitro
DNA-binding using a target sequence from the CZF1 promoter
region. Importantly, this mutant was also defective in the yeast-to-
hyphal transition during matrix-embedded growth at 25uC. The
importance of Arg321, a highly conserved residue within the
Cys6Zn2 motif of Czf1p, for DNA binding is consistent with the
role of the corresponding residue within the same sub-region of
other well-studied members of this class of transcriptional
regulators [27,29,30,31,32]. For example, substitution of Glu for
Lys at position 17 of S. cerevisiae Gal4 (analogous to Arg321 of
Czf1p) and substitution of Ala for Lys at position 44 in Leu3
(analogous to Lys322 of Czf1p) lead to an approximately 20-fold
and 15-fold reduction in DNA binding activity, respectively
[31,32]. Furthermore, substitution of Lys322 led to reduced DNA
binding and a defect in matrix-embedded filamentation. In
contrast, mutant Czf1T328A exhibited no defect in filamentation.
This result is consistent with previous structural studies of other
members of the Cys6Zn2 family, which showed that residues found
in this position and its proximity are facing away from DNA rather
than contacting the DNA [29,30].
Interestingly, the DNA-binding activity of Czf1p was separated
from its ability to physically interact with Efg1p. Czf1K322A and
Czf1R321l although defective in DNA-binding, were able to
interact with Efg1p. Importantly, our data indicate that the
Czf1p-Efg1p interaction detected by two-hybrid analysis does not
play an essential role in the ability of Czf1p to antagonize Efg1p
inhibitory function on filamentation. The EFG1-D3 mutant allele
encoding a mutant Efg1p that is defective in interaction with
Czf1p [28], complemented an efg1D null strain to the same extent
as wild type EFG1. If the physical binding of Czf1p to Efg1p were
the key mechanism to relieving Efg1p-mediated repression of
filamentation, the expected phenotype would have been a defect in
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Figure 4. Wild type and mutant Czf1p interact with Efg1p in
a yeast two-hybrid assay. S. cerevisiae strains carrying a lacZ reporter
plasmid, a lexA DNA-binding domain bait fusion (indicated below
columns) and a Gal4 activation domain prey fusion (black bars, Gal4AD-
Efg1; white bars, Gal4AD-Slk19) were grown in synthetic complete
medium lacking uracil, leucine and histidine (CM-ULH) and b-
galactosidase activity was determined using o-nitrophenyl b-D-galacto-
pyranoside (ONPG) as the substrate. Analysis was performed in triplicate
and mean and standard deviation are shown. Differences in activity of
Czf1-LexA fusions with Gal4AD-Efg1p and the same fusion with Gal4AD-
Slk19 were statistically significant (p,5610
24 for all Czf1-LexA fusions;
two tailed t test). (Panel B) S. cerevisiae strains were grown in CM-ULH
and immunoblot analysis was performed on crude extracts using an
anti-LexA antibody to visualize Czf1-lexA protein fusions. Actin was
detected as the loading control. Samples from two independent
cultures of a given strain are shown. Lanes 1 and 2, strain with lacZ
reporter and Gal4AD-Efg1 fusions only; lanes 3 and 4, strains carrying
lacZ reporter, Gal4AD-Efg1 and CZF1-lexA fusion; lanes 5 and 6, strains
carrying lacZ reporter, Gal4AD-Efg1 and czf1K322A-lexA fusion; lanes 7
and 8, strains carrying lacZ reporter, Gal4AD-Efg1 and czf1R321A-lexA
fusion. A cross-reacting band, marked with *, is apparent above the
Czf1-LexA fusion.
doi:10.1371/journal.pone.0039624.g004
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not observed.
Our findings are consistent with the model that Czf1p exerts its
positive influence on filamentation and relief of inhibition by
Efg1p, by acting at promoters via its DNA-binding activity. For
example, at the CZF1 promoter region both Czf1p and Efg1p
associate with sequences located upstream of the CZF1 ORF.
Importantly, in the cell, Czf1p and Efg1p bind independently to
the CZF1 promoter region [24]. Recent genome-wide association
studies conducted by ChIP-chip [21] confirm that Efg1p associates
with the CZF1 promoter region. In addition, in yeast form cells,
Efg1p binds to the promoters of several genes encoding negative
(Tcc1p, Nrg1p, Rfg1p and Cpp1p) and positive (Tec1p and
Def1p) regulators of filamentation [21]. We propose that the
effects of Efg1p on these (or other) promoters result in repression of
filamentation. In our model, during growth under matrix-
embedded conditions, Czf1p, via its DNA-binding activity, acts
at these or other promoters resulting in reversal of Efg1p-mediated
repression of filamentous growth. It appears that the Czf1p-Efg1p
physical interaction is dispensable for this event. This interaction
may be required for other functions of Czf1p or Efg1p.
When Czf1p levels are high enough, we propose that Czf1p
modulates and shuts down its own expression [23]. Therefore,
once its role as a positive regulator has been fulfilled, a negative
autoregulatory loop takes place. The transient function of Czf1p in
this model is analogous to the transient role of Czf1p in regulation
of switching between the more common ‘‘white’’ phenotype and
the mating competent ‘‘opaque’’ phenotype [17]. Temporal
regulation of multiple factors involved in the control of the
yeast-to-hyphal transition is thus a crucial mechanism for
regulating the different stages of initiation and maintenance of
filamentous growth [11,21,33].
The functional relationship between Czf1p and Efg1p in the
context of the yeast-to-hyphal transition is apparent only when
growth takes place within a semi-solid material at temperatures at
or below 35uC. These growth conditions likely simulate a specific
physical environment encountered during invasion into tissue in
particular parts of the body. In this environment, a distinct Czf1p/
Efg1p-dependent genetic program controlling morphogenesis is
important. To understand more broadly how morphogenesis is
triggered during infection of a human host, it will be of interest to
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Figure 5. A strain carrying an efg1 mutant defective in interaction with Czf1p behaves like a strain carrying one allele of wild-type
Efg1p during matrix-embedded growth. (Panel A) Strains with the genotypes shown at the top of the figure were grown embedded in YPS 1%
agar for 72 hours at 23uC. Two independent isolates of each strain were tested in duplicate. Representative colonies were photographed at 10x at the
times indicated. (Panel B) Quantitative representation of the percentage of filamentous colonies at various times. Data show the mean of the 4
determinations and the standard deviation. Black bar, 48 hours; grey bar, 72 hours. Differences in percent filamentous colonies between efg1D
mutant and other strains at 2 days were statistically significant (p,10
25; two tailed t test). (Panel C) Cells were grown in liquid YPD at 30uC and Efg1p
proteins were detected in cell extracts (45 mg total protein) by immunoblotting with anti-HA antibody. Actin was detected with anti-actin antiserum
as a loading control.
doi:10.1371/journal.pone.0039624.g005
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regulate filamentation in different environments.
Materials and Methods
Strains and media
C. albicans strains used in this study are listed in Table 2. C.
albicans cells were routinely grown in YP medium (1% yeast
extract, 2% Bacto peptone) with either 2% glucose (YPD) or 2%
sucrose (YPS). For embedding experiments, 1% agar was used.
For growth of CKY154 [ura3D czf1D cph1D mutant] [13] and its
derivatives carrying Myc-tagged CZF1 alleles, uridine was added
to the growth medium at 162 mg/ml. For czf1 mutant analysis,
plasmids encoding Myc-tagged CZF1 (wild type or mutant) under
control of the maltase promoter were linearized by digestion with
BsgI and integrated at the ADE2 locus of strain CKY154.
Transformants were selected for Nourseothricin resistance
(200 mg/mL) and integrations were confirmed using primers
ADE2-For1 and ADE2-Rev2 (Table 3). For efg1 mutant analysis,
plasmids pTD38-HA, pTD38-HA-Efg1 and pTD-HA-Efg1-D3
[28] encoding HA-tagged versions of EFG1 under control of the
endogenous promoter were linearized by digestion with PacI,
integrated at the EFG1 locus of strain Can35 [efg1D mutant] [5]
and correct integrations were confirmed by PCR with primers
EFG1-7a and EFG1-7b for vector alone and EFG1-10a and
EFG1–10b for EFG1 containing plasmids. E. coli DH5a[34], and
GM2163 (dam
2dcm
2; New England Biolabs) were used to
propagate plasmids. E. coli strain BL21 [35,36] was used for
expression and purification of recombinant Czf1p. Bacterial cells
were cultured in Luria broth or on Luria plates with ampicillin
added to a concentration of 100 mg/ml. S. cerevisiae strain EGY40
[37] was used for yeast-two-hybrid analysis carrying the bait and
prey fusions, and was grown routinely in complete minimal media
lacking uracil, leucine and histidine.
Matrix-embedding assay
Growth and embedding of C. albicans cells in agar medium was
performed as previously described [13]. Briefly, following 4 hours
of growth of a diluted overnight culture, C. albicans cells were
embedded in YPS containing 1% molten agar and grown at 25uC
for czf1 mutant analysis and 23uC for efg1 mutant analysis. Uridine
was added to 162 mg/ml for embedded growth of Ura
2 strains. A
colony was considered to be filamentous if more than 20 filaments
protruding from the edge of the colony were visible. 100 colonies
were counted for a given plate. Each assay described was
performed at least 3 times.
Plasmids
Plasmids used in this study are listed in Table 4.
Czf1p-Myc and HA-Efg1p. Wild-type or mutant Czf1-Myc
were expressed from the maltase promoter in plasmid pDBI-Czf1-
13xMyc-SAT. First, the vector pDBI52-SAT was constructed by
cloning SAT1 into plasmid pDBI52 [13]. Primers SAT1F and
SAT1R were used to amplify a fragment from pSFS2 [38]
containing the SAT1 marker. The PCR fragment was subcloned
into vector pDBI52. Cloning of CZF1-13xMyc-3UTR into pDBI-
SAT was done in two steps. First, an overlap PCR fragment of
13xMyc and the 39UTR of CZF1 was generated with pADH34
[39] amplified with primers MycF and MycR to generate the
13xMyc [AB] fragment and pTONY1 (an unpublished CZF1
+
plasmid isolated as described in [13]) with primers 3UTR-F and
CzfXba to generate the 39UTR [CD] fragment. The fragment was
then cloned into pDBI-SAT creating plasmid pDBI-13xMyc-
3UTR-SAT. Second, a PCR fragment containing the CZF1 ORF
and , 200bp upstream sequence was generated by primers
Czf1KpnI and CzfAge1 and cloned into pDBI-13xMyc-3UTR-
SAT. For this PCR, pMV102 [24] served as a template for wild-
type CZF1 and czf1 mutant alleles were generated by overlap
PCR. The resulting final plasmids carrying Myc-tagged Czf1p
variants and used for the embedding assay are: pDBI-Czf1R321A-
13xMyc-SAT, pDBI-Czf1K322A-13xMyc-SAT, pDBI-Czf1T328A-
13xMyc-SAT.
Yeast-two hybrid plasmids. A list of yeast-two-hybrid
plasmids used in this study is provided in Table 4. To create
plexA-Czf1R321A and plexA-Czf1K322A plasmids pDBI-Czf1R321A
and pDBI-Czf1K322A served as templates using primers BOPO1
and BOPO2. The CZF1 ORF-containing PCR fragment was then
Table 2. C. albicans stains used in this study.
Name Genotype Source or reference
C. albicans
SC5314 Clinical isolate [41]
CAI-4 SC5314 Dura3::imm434/Dura3::imm434 [41]
CKY154 CAI-4 czf1::hisG/czf1::hisG cph1::hisG/cph1::hisG [13]
Can35 CAI-4 efg1::hisG/efg1::hisG Dura3::imm434/Dura3::imm434 [5]
IPC11 CKY154 ade2::pDBI52-SAT This study
IPC22 CKY154 ade2::pDBI-Czf1-13xmyc-SAT This study
IPC31 CKY154 ade2::pDBI-Czf1K322A-13xmyc-SAT This study
IPC42 CKY154 ade2::pDBI-Czf1R321A-13xmyc-SAT This study
IPC51 CKY154 ade2::pDBI-Czf1T328A-13xmyc-SAT This study
IPE1.3 HLC67 efg1::hisG/efg1::pTD38 This study
IPE2.3 HLC67 efg1::hisG/efg1:: pTD38-EFG1 This study
IPE7 HLC67 efg1::hisG/efg1::pTD38-EFG1-D3 This study
S. cerevisiae
EGY40 MAT ura3–1 his3–11 trp1–1 leu2–3,112 [37]
doi:10.1371/journal.pone.0039624.t002
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[14] digested with the same enzymes.
GST fusion proteins for expression in E. coli. Wild-type
GST-Czf1 was published previously [23]. To create GST fusions
of mutant czf1, primers POM1F and POM1R were used to
amplify CZF1 alleles using templates pDBI-Czf1R321A and pDBI-
Czf1K322A. After subsequent digestion with BamHI and EcoRI the
PCR fragments were cloned into plasmid pGEX-6P-2 (GE
Healthcare Life Sciences) digested with the same enzymes, giving
rise to pGST-Czf1R321A and pGST-Czf1K322A.
Western analysis
Strains producing Myc-tagged Czf1p variants under control of
the maltase promoter were grown in YPS at 30uCt oO D 600 of
0.8–1. Strains producing HA-tagged Efg1p variants under
transcriptional control of the endogenous promoter were grown
similarly and as in [28]. Crude cell extracts were prepared by
breakage with glass beads, in the presence of protease inhibitors
(2 mM PMSF, one tablet Complete mini protease inhibitor
cocktail (Roche) per 10 ml lysis buffer). Lysis buffer, RIPA, was:
50 mM TrisCl, pH 7.5, 150 mM NaCl, 0.1% SDS, 0.5% Sodium
Deoxycholate, 1% NP40. Total protein was quantified with the
BCA assay (Thermo Scientific). 30 mg of total protein for Czf1-
Myc and 45 mg of total protein for HA-Efg1 were used. Proteins
were separated by 8% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE), and immunoblottings were done
using mouse anti-Myc (1:2,000, Upstate) for Czf1-Myc and mouse
anti-HA high-affinity antibody (1:1,000; Roche) for HA-Efg1. For
visualization of Czf1-lexA protein fusion in the yeast-two-hybrid
assay, cells were grown to exponential phase, harvested, adjusted
to 10 OD600 units and crude extracts were obtained using M2 lysis
buffer pH 7.0 (20 mM HEPES, 150 mM NaCl) and protease
inhibitors (Complete mini protease inhibitor cocktail, Roche).
Immunoblottings were done using rabbit anti-LexA antibody (1:1,
5000, Sigma).
Table 3. Primers used in this study.
A. czf1 mutant construction by overlap PCR
R321A–F CGTATGGGATGTCTTACATGCCGTCAAGCAAAGAAACGTTGTTGTGAAACAAGACCAAGG
R321A–R CCTTGGTCTTGTTTCACAACAACGTTTCTTTGCTTGACGGC
K322A–F GGGATGTCTTACATGCCGTCAAAGAGCTAAACGTTGTTGTGAAACAAGACCAAGG
K322A–R TCTTTGACGGCATGTAAGACATCCC
T328A–F GCCGTCAAAGAAAGAAACGTTGTTGTGAAGCAAGACCAAGGTGTACTGAGTGCAC
T328A–R TTCACAACAACGTTTCTTTCTTTGACGGC
B. Construction of myc tagged CZF1 alleles
SAT1-F TGCTCTAGATCATAAAATGTCGAGCGTCAAAACT
SAT1-R GGTGAATTCGAATTCGAACTTCCTGCAGGACCACCTT
MycF GGTAGGCCTGGTACCATATACCGGTGGTGGTCGGATCCCCGGGTTAATTAA
MycR CCTCCAACACAGAGAAGCCTCGAGCGCGAATTCACTAGTGATTGATTAA
3UTR-F CAATCACTAGTGAATTCGCGCTCGAGGCTTCTCTGTGTTGGAGGGATA
Czf-Stu GCAGGCCTTATCTGTTCACCCCATTTCTTTCA
Czf-Xba GCTCTAGAATTTCGTTTTGCTGGTGCTGTG
Czf-Kpn1 GCAGGTACCTATCTGTTCACCCCATTTCTTTCA
Czf-AgeI GTGACCGGTTTTACTTCTGTATTCAACAATACC
C. Construction of Czf1-lexA fusions:
BOPO1 GGTGAATTCCATTCAAACGAAAACTATCTGGT
BOPO2 GGTGGATCCTACTTCTGTATTCAACAATACCT
D. Construction of GST-Czf1 fusions
POM1-F CGGGATCCATGAGTTCAATACCCAATATCAAT
POM1-R CGAATTCTTATTTACTTCTGTATTCAACAATAC
E. Amplification of fragment E for mobility shift assay analysis
Czf1A–F CAAAACAAGCCAGAATAAAAATA
Czf1A–R ACCGGAAGTACCAAAAGAGTC
F. Confirmation of proper integrations of CZF1-myc and HA-EFG1 constructs in C. albicans:
ADE2 For1 CGGTACAATCTTGTCAATGAGATGGA
ADE2 Rev2 ATGCTTCCGGCTCGTATGTTGTGT
EFG1-7a ACTGAGGGCTTTGGTCGTGGT
EFG1-7b ATCCCTGCAGCCCGGGGAAT
EFG1-10a ACAGCCAGAGTCAAGCTAAAGCAAG
EFG1-10b ATGCAGCTCCCGGAGACGGT
doi:10.1371/journal.pone.0039624.t003
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For purification of GST-Czf1p, 1.2 L of cells were grown to
OD600#0.8 at 25uC and induced with 0.5 mM IPTG at 30uC for
2.5 hrs. Cells were harvested and resuspended in ice cold 1xPBS (8
mM sodium phosphate, 2 mM potassium phosphate, 140 mM
NaCl, 10 mM KCl, ph 7.4) containing a cocktail of protease
inhibitors (Roche, EDTA free) and 2 mM PMSF, and passed
twice through a French pressure cell at 14,000 psi. The lysate was
cleared by ultracentrifugation at 90,000 r.p.m. for 20 min in
a Beckman TLA 100.3 rotor. The cleared lysate was loaded onto
a pre-equilibrated glutathione Sepharose column. The resin was
washed with three times the bed volume with 1xPBS. Protein was
first eluted with 50 mM Tris, pH 8.0, 10 mM reduced glutathione
and then with 125 mM Tris, pH 8.0, 150 mM NaCl, 50 mM
reduced glutathione. Protein from the second elution was used for
gel shift analysis.
Mobility shift assay
Primers CZF1AF/CZF1AR (Table 3) were used to amplify
a 565 bp fragment from the CZF1 promoter, which was denoted
the fragment E [23]. DNA probes were gel-purified and labeled
with [c-
32P] ATP using T4 polynucleotide kinase (New England
Biolabs) and the manufacturer’s protocol. Mobility shift experi-
ments were modified from previously published procedures [23].
Binding reactions were performed in a 20 mL reaction that
contained the following components: 12% (v/v) glycerol, 12 mM
HEPES-NaOH (pH 7.9), 4 mM Tris-Cl (pH 7.9), 90 mM KCl,
2 mg poly(dI-dC), 5 mg BSA, 0.625 ng
32P-labelled oligonucleotide
probe, and varying amounts of protein. After incubation for
30 min at 30uC, the binding mixture was separated on 8%
polyacrylamide, Tris-Glycine non-denaturing gel (50 mM Tris
pH 8.0, 383.6 M Glycine), at room temperature in the absence of
chelating agents. Running buffer was 35 mM HEPES, 43 mM
Immidazole, pH 7.4. Dried gels were visualized by phosphorima-
ging.
Yeast-two-hybrid analysis
The assay was performed as discussed previously [14]. Briefly, S.
cerevisiae strain EGY40 carrying the lacZ reporter plasmid pSH18–
34 [37] was transformed with GAL4-AD plasmids (pKLEF4
encoding Gal4AD-Efg1, and pC1.1.2 encoding Gal4AD-Slk19)
and LexA-DBD plasmids (pBOM1a encoding Czf1-lexA;
Czf1R321A-lexA, Czf1K322A-lexA, and plexA-Fos) using standard
methods [40]. For quantitative analyses, strains were grown
overnight in synthetic complete medium lacking uracil, histidine,
and leucine. Cells were diluted into fresh medium, grown to an
OD600 of 0.6–0.9, harvested and ß-galactosidase activity was
determined using o-nitrophenyl ß-D-galactopyranoside as the
substrate. Analyses were done in triplicate. Control fusion proteins
not expected to interact with Efg1p and Czf1p are lexA-Fos and
Gal4AD-Slk19, respectively.
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